About: covid:arg/99f900efe9f40ad2a210943a2aff4b42c4beb2c3/4   Goto Sponge  NotDistinct  Permalink

An Entity of Type : amo:Claim, within Data Space : covidontheweb.inria.fr associated with source document(s)

AttributesValues
type
wasQuotedFrom
aif:claimText
  • Coronavirus disease 2019 , SARS - CoV - 2 , hypertension , angiotensin converting enzyme inhibitor , angiotensin II receptor blocker prospective and randomized - controlled trials are needed , this study adds to a growing body of evidence that continuation of ACEI / ARB therapy , appears to be safe and further supports current societal recommendations by ACC / AHA / HFSA to continue ACEI / AR
is hasSource of
is sioca:supports of
is has claim of
is proves of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software